Ferjancic Benetik S

General

Full name : Benetik Svit Ferjancic

First name : Svit Ferjancic Benetik

Mail : Faculty of Pharmacy, University of Ljubljana

Zip Code :

City :

Country : Slovenia

Email :

Phone :

Fax :

Website :

Directory :

Comment

References (3)

Title : Targeting Neuroinflammation and Cognitive Decline: First-in-Class Dual Butyrylcholinesterase and p38alpha Mitogen-Activated Protein Kinase Inhibitors - Ferjancic Benetik_2025_J.Med.Chem__
Author(s) : Ferjancic Benetik S , Proj M , Knez D , Kosak U , Meden A , Krajsek K , Pislar A , Horvat S , Svajger U , Tesic N , Pulkrabkova L , Soukup O , Skarka A , Andrys R , Brazzolotto X , Igert A , Nachon F , Dias J , Detka J , Gdula-Argasinska J , Wyska E , Szafarz M , Manik A , Plachtij N , Musilek K , Salat K , Obreza A , Gobec S
Ref : Journal of Medicinal Chemistry , : , 2025
Abstract :
PubMedSearch : Ferjancic Benetik_2025_J.Med.Chem__
PubMedID: 40779804

Title : Dual Cholinergic Modulation in Dementia: Quinuclidine Carbamates Targeting Butyrylcholinesterase and alpha7 Nicotinic Receptor - Mastnak-Sokolov_2025_Chem.Biol.Interact_15ChEPon__111830
Author(s) : Mastnak-Sokolov P , Knez D , Meden A , Strasek Benedik N , Ferjancic Benetik S , Hrast Rambaher M , Zorman M , Nachon F , Brazzolotto X , Jardemark K , Jungholm O , Bruton J , Strandback E , Nyman T , Shahid M , Gobec S
Ref : Chemico-Biological Interactions , :111830 , 2025
Abstract :
PubMedSearch : Mastnak-Sokolov_2025_Chem.Biol.Interact_15ChEPon__111830
PubMedID: 41242410
Gene_locus related to this paper: human-BCHE

Title : Dual inhibition of butyrylcholinesterase and p38alpha mitogen-activated protein kinase: A new approach for the treatment of Alzheimer's disease - Ferjancic Benetik_2024_Pharmacol.Ther__108748
Author(s) : Ferjancic Benetik S , Knez D , Obreza A , Kosak U , Gobec S
Ref : Pharmacol Ther , :108748 , 2024
Abstract :
PubMedSearch : Ferjancic Benetik_2024_Pharmacol.Ther__108748
PubMedID: 39521443